2007
DOI: 10.1002/jnr.21311
|View full text |Cite
|
Sign up to set email alerts
|

Identification of molecular compounds critical to Alzheimer's‐like plaque formation

Abstract: Amyloid diseases are characterized by the formation of insoluble amyloid fibrils from previously soluble polypeptides. In Alzheimer's disease (AD), amyloid fibrils, formed from beta-amyloid peptides, are deposited as extracellular amyloid plaques only inside the brain. As previously shown, Alzheimer's-like plaque formation in human monocyte culture recapitulates the features of in vivo amyloid plaque formation. Here we show that this cell model can be used to screen compounds that potentially influence amyloid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 51 publications
0
2
0
Order By: Relevance
“…In human brain, myo -inositol is the most abundant stereoisomer (Haris et al ., 2011) and forms small stable micelles with the Aβ peptide (McLaurin et al ., 1998). Amyloid fibril formation is inhibited by myo -inositol (Gellermann et al ., 2007), and complexation of Aβ with inositol protects neuronal cultures from Aβ toxicity (McLaurin et al ., 2000). Similarly, the scyllo -inositol stereoisomer inhibits amyloid formation (Li et al ., 2012; Ma et al ., 2012), and treatment of animal AD models with scyllo -inositol reduces plaque formation and improves memory performance and hippocampal synaptic plasticity (McLaurin et al ., 2006; Aytan et al ., 2013).…”
Section: Discussionmentioning
confidence: 99%
“…In human brain, myo -inositol is the most abundant stereoisomer (Haris et al ., 2011) and forms small stable micelles with the Aβ peptide (McLaurin et al ., 1998). Amyloid fibril formation is inhibited by myo -inositol (Gellermann et al ., 2007), and complexation of Aβ with inositol protects neuronal cultures from Aβ toxicity (McLaurin et al ., 2000). Similarly, the scyllo -inositol stereoisomer inhibits amyloid formation (Li et al ., 2012; Ma et al ., 2012), and treatment of animal AD models with scyllo -inositol reduces plaque formation and improves memory performance and hippocampal synaptic plasticity (McLaurin et al ., 2006; Aytan et al ., 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Heparin has been found to induce aggregation and b-sheet formation. 10,11 Sulfated GAGs have frequently been identified as potential physiological ligands of PrP C , creating oligomeric complexes with PrP. 12 However, there are contradictory hypotheses about the role of GAGs in the infection, since both enhancing and inhibiting effects have been identified.…”
Section: Introductionmentioning
confidence: 99%